INACTIVE
Full-Time
Associate Director
Pipeline & Portfolio Market Planning
Posted on 4/18/2024
Develops cortisol modulation technologies for diseases
Biotechnology
Compensation Overview
$204,500 - $240,600Annually
Senior
Menlo Park, CA, USA
Required Skills
Data Analysis
Requirements
- Ability to master new therapeutic areas across multiple perspectives including scientific, clinical, commercial, and regulatory
- Solid understanding of market research principles
- Ability to develop and deliver compelling presentations to senior management
- Ability to rapidly synthesize information from multiple sources, communicate ideas and data both verbally and written in a persuasive manner
- Ability to lead across a matrixed organization and to integrate cross-functional thinking into a clear strategy
- Strong understanding of the drug development process for early through late-stage programs
- Occasional travel required for corporate and industry events
- Bachelor's degree required. Advanced degree preferred (MBA, MSc, PhD, PharmD)
- 5+ years in product planning preferred, with relevant professional experience in new product planning, market planning, corporate development and/or healthcare strategy consulting considered
- Industry experience within oncology required
- Experience on a cross-functional drug development team preferred
Responsibilities
- Lead program-level strategy projects and initiatives in support of maximizing portfolio value
- Synthesize data from various sources including primary market research, secondary data, and analytics into actionable insights
- Provide physician, patient, and payer perspective into clinical strategy and planning
- Develop & maintain long-range revenue forecasts and valuations for new programs
- Develop competitive intelligence tracking tools and analysis to support programs
- Work cross-functionally with Commercial teams and Development organization to support integrated planning activities
- Create and manage target product profiles (TPPs) for pipeline products, working with development team to influence and support clinical development decisions
- Manage ad hoc strategic projects across portfolio
- Conduct asset assessments and due diligence for business development opportunities
Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.
Company Stage
IPO
Total Funding
$119.1M
Headquarters
Menlo Park, California
Founded
1998
Growth & Insights
Headcount
6 month growth
↑ 10%1 year growth
↑ 19%2 year growth
↑ 42%INACTIVE